Chronic Pain in Parkinson's Disease: Prevalence, Sex Differences, Regional Anatomy and Comorbidities [0.03%]
帕金森病的慢性疼痛：患病率、性别差异、区域解剖和共病
Natalia S Ogonowski,Freddy Chafota,Fangyuan Cao et al.
Natalia S Ogonowski et al.
Objective: Chronic pain is prevalent among people living with Parkinson's disease (PD). We analyzed data from 10,631 Australian individuals with PD to assess the prevalence, age and sex differences, severity, anatomical d...
CSF Mitochondrial DNA: Biomarker of Body Composition and Energy Metabolism in Parkinson's Disease [0.03%]
脑脊液线粒体DNA：帕金森病体重组成和能量代谢的生物标志物
Yasuaki Mizutani,Tsuyoshi Nakai,Yasuhiro Maeda et al.
Yasuaki Mizutani et al.
Objective: Cerebrospinal fluid (CSF) cell-free mitochondrial DNA (cf-mtDNA) is a potential biomarker for Parkinson's disease (PD), but its clinical relevance remains unclear. We investigated associations between CSF cf-mt...
Sharan R Srinivasan,Amy D Mook,Michelle Rochman et al.
Sharan R Srinivasan et al.
Objective: Over the past decade, significant advances in genetic testing for ataxia have improved diagnostic accuracy, informed clinical trial eligibility, guided treatment decisions, and enabled cascade testing of at-ris...
Letter on "Real-World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell-Based Assay" [0.03%]
关于“针对MOG和AQP4抗体检测的活细胞与固定细胞基底测定方法的真实世界临床经验”的信件
Raveena Vij,Alexander J Jonokuchi,Ilya Kister
Raveena Vij
Circulating Interleukin-6 Levels and Timing of Acute Ischemic Stroke Onset [0.03%]
急性缺血性卒中的循环IL-6水平与发病时间的关系
Robert G Kowalski,Aurélie Ledreux,John E Violette et al.
Robert G Kowalski et al.
Intravenous thrombolysis is the most widely available effective ischemic stroke treatment, but is approved only if given within 4.5 h from stroke onset. Many patients are not treated because stroke onset time is unknown. We evaluated the cy...
Identification of Dementia With Lewy Bodies by Skin Biopsy in Recent-Onset Cognitive Impairment [0.03%]
通过皮肤活检在近期出现的认知障碍患者中识别路易体痴呆
Alessandro Furia,Alex Incensi,Cecilia Delprete et al.
Alessandro Furia et al.
Immunofluorescence for phosphorylated alpha-synuclein in skin biopsy samples is an emerging biomarker in synucleinopathies comprising Dementia with Lewy bodies. In this pilot study, 19 patients with recent-onset (≤ 18 months) cognitive imp...
Commentary on "The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type" [0.03%]
“糖尿病和代谢综合征对疼痛、神经病严重程度和纤维类型的影响”的社论
Majid Khalilizad,Ebrahim Hejazian,Mohammad Barary et al.
Majid Khalilizad et al.
Real World Effectiveness and Tolerability of Novel Monoclonal Antibodies and Rituximab for NMOSD [0.03%]
新型单克隆抗体与利妥昔单抗治疗NMOSD真实世界有效性和耐受性的研究
Zarmina Javed,Mengke Du,Mary Rensel et al.
Zarmina Javed et al.
In this multicenter retrospective cohort study of 135 people with aquaporin-4 IgG+ neuromyelitis optica spectrum disorder (NMOSD), some of whom were exposed to multiple therapies, we evaluated the effectiveness and tolerability of rituximab...
NMDAR-Antibody Encephalitis Diagnosed With Primary Central Nervous System Lymphoma: A Case Series [0.03%]
以中枢神经系统淋巴瘤为首发表现的抗N-甲基-D天冬氨酸受体脑炎系列病例报告
Soo Hyun Ahn,Cynthea Prima,Tae Min Kim et al.
Soo Hyun Ahn et al.
N-methyl-D-aspartate receptor-antibody encephalitis (NMDAR encephalitis) is one of the most common forms of autoimmune encephalitis, with a paraneoplastic relationship described in approximately 38%. Primary central nervous system lymphoma ...
Response to: Clinical Imaging Features of Sporadic and Genetic Frontotemporal Lobar Degeneration TDP-43 A and B [0.03%]
对散发性和遗传性额颞叶变性TDP-43 A和B的临床影像特征的回应
Sergi Borrego-Écija,Cèlia Cruz-Escalera,Agnes Perez-Millán et al.
Sergi Borrego-Écija et al.